ABRYSVO Trademark

Trademark Overview

On Thursday, September 9, 2021, a trademark application was filed for ABRYSVO with the United States Patent and Trademark Office. The USPTO has given the ABRYSVO trademark a serial number of 97018602. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by Pfizer Inc.. The ABRYSVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a human vaccine
abrysvo

General Information

Serial Number97018602
Word MarkABRYSVO
Filing DateThursday, September 9, 2021
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7208399
Registration DateTuesday, October 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, a human vaccine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 18, 2021
Primary Code005
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, September 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, September 11, 2023USE AMENDMENT FILED
Monday, September 18, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 11, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, July 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 10, 2023SOU EXTENSION 2 GRANTED
Monday, July 10, 2023SOU EXTENSION 2 FILED
Monday, July 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 5, 2023SOU EXTENSION 1 GRANTED
Thursday, January 5, 2023SOU EXTENSION 1 FILED
Thursday, January 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 30, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 26, 2022ASSIGNED TO EXAMINER
Monday, October 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 13, 2021NEW APPLICATION ENTERED

Related Keywords

abrysvo vaccine human namely preparations pharmaceutical